carvedilol 25 mg
1 INDICATIONS AND USAGE Carvedilol tablets are an alpha-/beta-adrenergic blocking agent indicated for the treatment of: ā¢ mild to severe chronic heart failure ( 1.1 ) ā¢ left ventricular dysfunction following myocardial infarction in clinically stable patients ( 1.2 ) ā¢ hypertension ( 1.3 ) 1.1 Heart Failure Carvedilol tablets are indicated for the treatment of mild-to-severe chronic heart failure of ischemic or cardiomyopathic origin, usually in addition to diuretics, ACE inhibitors, and digitalis, to increase survival and, also, to reduce the risk of hospitalization [see Drug Interactions ( 7.4 ), Clinical Studies ( 14.1 )]. 1.2 Left Ventricular Dysfunction following Myocardial Infarction Carvedilol tablets are indicated to reduce cardiovascular mortality in clinically stable patients who have survived the acute phase of a myocardial infarction and have a left ventricular ejection fraction of less than or equal to 40% (with or without symptomatic heart failure) [see Clinical Studies ( 14.2 )]. 1.3 Hypertension Carvedilol tablets are indicated for the management of essential hypertension [see Clinical Studies ( 14.3 , 14.4 )]. It can be used alone or in combination with other antihypertensive agents, especially thiazide-type diuretics [see Drug Interactions ( 7.2 )].
glenmark pharmaceuticals inc., usa
Related Pills
carvedilol 25 mg
Glenmark Pharmaceuticals Inc., USA
carvedilol 12.5 mg
Glenmark Pharmaceuticals Inc., USA
carvedilol 12.5 mg
Glenmark Pharmaceuticals Inc., USA
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING
CARVEDILOL Tablets, USP are available in the following strengths: 3.125 mg ā white, film-coated circular shaped tablets with āGā engraved on one side and plain on the other side, 6.25 mg ā white, film-coated circular shaped tablets with āGā engraved on one side and ā41ā engraved on the other side, 12.5 mg ā white, film-coated capsule shaped tablets with āGā engraved on one side and ā164ā engraved on the other side, 25 mg ā white, film-coated circular shaped tablets with āG41ā engraved on one side and ā25ā engraved on the other side. ā¢ 3.125 mg 60ās: NDC 68462-162-60 100ās: NDC 68462-162-01 180ās: NDC 68462-162-18 500ās: NDC 68462-162-05 1000ās: NDC 68462-162-10 ā¢ 6.25 mg 60ās: NDC 68462-163-60 100ās: NDC 68462-163-01 180ās: NDC 68462-163-18 500ās: NDC 68462-163-05 1000ās: NDC 68462-163-10 ā¢ 12.5 mg 60ās: NDC 68462-164-60 100ās: NDC 68462-164-01 180ās: NDC 68462-164-18 500ās: NDC 68462-164-05 1000ās: NDC 68462-164-10 ā¢ 25 mg 60ās: NDC 68462-165-60 100ās: NDC 68462-165-01 180ās: NDC 68462-165-18 500ās: NDC 68462-165-05 1000ās: NDC 68462-165-10 Store at 20Ā°C to 25Ā°C (68Ā°F to 77Ā°F) [see USP Controlled Room Temperature]. Protect from moisture. Dispense in a tight container.
More pills like ROUND G41 25